ALIVUS Results Dashboard

Earnings Analysis Dashboard – ALIVUS

Structured AI analysis of company financial results designed to help traders and investors quickly understand key performance trends.

Type of Announcement

The Board of Directors of Alivus Life Sciences Limited approved the audited financial results for the quarter and year ended March 31, 2026, and recommended a final dividend of Rs. 5 per equity share for the financial year 2025-26.

Revenue

₹689.12 Crs.

▲ +2.4% QoQ

Net Profit

₹162.66 Crs.

▲ +14.7% YoY

EPS

13.23

▲ +8.0% QoQ

EBITDA Margin

N/A

Key Financial Numbers (Quarter)

Metric	Current Quarter (Mar 2026)	Previous Quarter (Dec 2025)	Same Quarter Last Year (Mar 2025)
Revenue (₹ Crs.)	689.12	672.89	649.54
Net Profit (₹ Crs.)	162.66	150.26	141.87
EPS	13.23	12.25	11.57
EBITDA Margin (%)	N/A	N/A	N/A

What EPS Means
EPS (Earnings Per Share) shows how much profit a company generates for each share. Higher EPS usually indicates stronger profitability and better earnings power for shareholders.

What EBITDA Margin Means
EBITDA Margin measures operating profitability before interest, tax, depreciation and amortization. A higher margin suggests the company is generating stronger operating profits from its revenue.

Revenue Trend

Mar 2026 ₹689.12 Crs.

Dec 2025 ₹672.89 Crs.

Mar 2025 ₹649.54 Crs.

Profit Trend

Mar 2026 ₹162.66 Crs.

Dec 2025 ₹150.26 Crs.

Mar 2025 ₹141.87 Crs.

Quick Interpretation

QoQ revenue trend: Strong recovery (+2.4%)
YoY revenue trend: Positive growth (+6.1%)
QoQ profit trend: Improved performance (+8.2%)
YoY profit trend: Significant increase (+14.7%)

Major Corporate Events

Recommendation of a final dividend of Rs. 5 per equity share for the financial year 2025-26.

Trading Signals

Positive Factors: Strong profit growth YoY and QoQ.
Negative Factors: N/A

Overall Sentiment

Bullish

Disclaimer

This report has been analysed and generated using AI based on publicly available corporate announcements and financial disclosures published by the company on NSE INDIA Website.

We are not registered with SEBI as an investment advisor or research analyst. This report is provided strictly for informational and educational purposes only.

Investors should not treat this analysis as financial advice, stock recommendation, or investment guidance. Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.

The platform does not guarantee accuracy, completeness, or timeliness of the extracted information.